Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
21
pubmed:dateCreated
1985-12-5
pubmed:abstractText
Bacterial lipopolysaccharide (LPS) induces proliferation of resting primary murine B lymphocytes and their differentiation into Ig-secreting cells. This is accompanied by an increase in the rate of Ig gene transcription and the accumulation of mu heavy chain secretory mRNA. Specific antiantigen receptor antibody (anti-mu) induces resting B cells to proliferation but not differentiation. Upon addition of both LPS and anti-mu to cultures, resting B cells again proliferate but do not differentiate. RNA transfer blots of the Ig mRNA 2 days after induction with LPS/anti-mu show a specific deficiency of the 2.4-kilobase (kb) mu secretory mRNA, whereas the levels of the 2.7-kb mu membrane and 1.2-kb kappa light chain mRNAs are as high as in cells treated with LPS alone. Between days 3 and 4 after treatment with both reagents, reductions of mu membrane and, to a smaller extent, kappa mRNA become apparent. As measured by nuclear run-on transcription experiments at day 2, the transcription rates of Ig mu and the Ig kappa transcription units are equal in both induction experiments. Only at later stages do the LPS/anti-mu-treated cells transcribe Ig genes at a lower rate. Thus, the anti-mu treatment, drastically reducing the mu secretory mRNA production at early stages, represents a negative regulation occurring primarily at the posttranscriptional level.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/3933005-1094630, http://linkedlifedata.com/resource/pubmed/commentcorrection/3933005-4214706, http://linkedlifedata.com/resource/pubmed/commentcorrection/3933005-479179, http://linkedlifedata.com/resource/pubmed/commentcorrection/3933005-4831907, http://linkedlifedata.com/resource/pubmed/commentcorrection/3933005-518835, http://linkedlifedata.com/resource/pubmed/commentcorrection/3933005-6034749, http://linkedlifedata.com/resource/pubmed/commentcorrection/3933005-6086008, http://linkedlifedata.com/resource/pubmed/commentcorrection/3933005-6159641, http://linkedlifedata.com/resource/pubmed/commentcorrection/3933005-6206193, http://linkedlifedata.com/resource/pubmed/commentcorrection/3933005-6242466, http://linkedlifedata.com/resource/pubmed/commentcorrection/3933005-6262826, http://linkedlifedata.com/resource/pubmed/commentcorrection/3933005-6300842, http://linkedlifedata.com/resource/pubmed/commentcorrection/3933005-6304638, http://linkedlifedata.com/resource/pubmed/commentcorrection/3933005-6319016, http://linkedlifedata.com/resource/pubmed/commentcorrection/3933005-6324080, http://linkedlifedata.com/resource/pubmed/commentcorrection/3933005-6329676, http://linkedlifedata.com/resource/pubmed/commentcorrection/3933005-6335303, http://linkedlifedata.com/resource/pubmed/commentcorrection/3933005-6409418, http://linkedlifedata.com/resource/pubmed/commentcorrection/3933005-6409653, http://linkedlifedata.com/resource/pubmed/commentcorrection/3933005-6548414, http://linkedlifedata.com/resource/pubmed/commentcorrection/3933005-6594679, http://linkedlifedata.com/resource/pubmed/commentcorrection/3933005-6604127, http://linkedlifedata.com/resource/pubmed/commentcorrection/3933005-6606489, http://linkedlifedata.com/resource/pubmed/commentcorrection/3933005-6771019, http://linkedlifedata.com/resource/pubmed/commentcorrection/3933005-6774873, http://linkedlifedata.com/resource/pubmed/commentcorrection/3933005-6776490, http://linkedlifedata.com/resource/pubmed/commentcorrection/3933005-6806371, http://linkedlifedata.com/resource/pubmed/commentcorrection/3933005-6812053, http://linkedlifedata.com/resource/pubmed/commentcorrection/3933005-6819799, http://linkedlifedata.com/resource/pubmed/commentcorrection/3933005-6895103, http://linkedlifedata.com/resource/pubmed/commentcorrection/3933005-802472, http://linkedlifedata.com/resource/pubmed/commentcorrection/3933005-87465
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:volume
82
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
7384-8
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1985
pubmed:articleTitle
IgM RNA switch from membrane to secretory form is prevented by adding antireceptor antibody to bacterial lipopolysaccharide-stimulated murine primary B-cell cultures.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't